Track InMode Ltd. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

InMode Ltd. INMD Open InMode Ltd. in new tab

14.10 USD
P/E
10.07
EPS
1.43
P/B
1.34
ROE
13.53
Beta
1.98
Target Price
17.00 USD
InMode Ltd. logo

InMode Ltd.

🧾 Earnings Recap – Q1 2026

Shares dropped 3.3% following earnings as investors reacted to margin compression and cautious outlook reflected in weaker profitability metrics despite modest revenue growth.

  • Revenue rose 5% year-over-year to $82 million, driven primarily by the U.S. market; international sales grew 2.65% to $38.7 million.
  • Gross margin declined significantly, with GAAP gross margin falling to 75% from 78% a year ago and non-GAAP gross margin down to 75% from 79%.
  • Operating expenses increased sharply, with GAAP operating expenses up 13.7%, largely due to restructuring of North American sales and expansion efforts.
  • Operating margins compressed notably, as GAAP operating margin dropped to 12% from prior levels, and non-GAAP operating margin declined to 17% from 23%.
  • Earnings per share declined: GAAP EPS fell to $0.18 from $0.26, and non-GAAP EPS decreased to $0.25 from $0.31, underscoring margin pressure and cautious execution.
📅
Loading chart...
Key Metrics
Earnings dateJuly 23, 2026
P/E10.07
EPS1.43
Book Value10.78
Price to Book1.34
Debt/Equity1.20
% Insiders11.912%
Growth
Revenue Growth0.06%
Earnings Growth-0.64%
Estimates
Forward P/E9.41
Forward EPS1.53
Target Mean Price17.00

DCF Valuation

Tweak assumptions to recompute fair value for InMode Ltd. (INMD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

InMode Ltd. Logo InMode Ltd. Analysis (INMD)

Israel Health Care Official Website Stock

Is InMode Ltd. a good investment? InMode Ltd. (INMD) is currently trading at 14.10 USD. Market analysts have a consensus price target of 17.00 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 10.07. This relatively low multiple may signal that InMode Ltd. is undervalued compared to historical market norms.

Earnings Schedule: InMode Ltd. is expected to release its next earnings report on July 23, 2026. The market consensus estimate for Forward EPS is 1.53.

Investor FAQ

Does InMode Ltd. pay a dividend?

No, it does not currently pay a dividend.

What asset class is InMode Ltd.?

InMode Ltd. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 23, 2026. The company currently has a trailing EPS of 1.43.

Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Exchange Ticker
NMS (United States) INMD

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Oct. 1, 2021 2.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion